Analysis: Baerveldt implant reduces IOP more than Ahmed glaucoma valve

CORONADO, Calif. — On average over time, the Baerveldt glaucoma implant reduced IOP significantly more than the Ahmed glaucoma valve but with more sight-threatening complications, Donald L. Budenz, MD, MPH, said at the American Glaucoma Society meeting.Budenz presented a 5-year analysis of pooled data from the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study, both randomized clinical trials.

Full Story →